Molecular engineering human hepatocytes into pancreatic beta cells for diabetes therapy.
Cozar-Castellano
Irene
I
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Stewart
Andrew F
AF
D002454:Cell Differentiation; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D022781:Hepatocytes / Q000166:cytology*; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology*; D015534:Trans-Activators / Q000235:genetics*; D014161:Transduction, Genetic / Q000379:methods
D018398:Homeodomain Proteins; D015534:Trans-Activators; C084010:pancreatic and duodenal homeobox 1 protein